The European Union has granted CE mark to Hygieia's new diabetes insulin guidance system (DIGS), designed for insulin treated patients with poor glycemic control. The d-Nav system automatically updates insulin dosage as needed and ...
Tags: Hygieia, DIGS, CE mark, diabetes insulin guidance system, glycemic control
CeQur, a developer of wearable delivery devices, has started a clinical study of PaQ insulin delivery device. The PaQ study is conducted by Thomas Pieber, head of endocrinology and metabolism division at Austria University Hospital. The ...
Tags: CeQur, clinical study, PaQ insulin delivery device, PaQ study
Sanofi, a provider of diabetes devices, has opened a Lantus SoloSTAR Pen assembly plant in Beijing, china. The Lantus SoloSTAR plant with a capacity of 48 million units per year is designed to produce Lantus SoloSTAR pre-filled insulin ...
Tags: Sanofi, assembly plant, diabetes devices, Lantus SoloSTAR plant
Chicago-based Palladium Energy, a Marlin Equity Partners' portfolio company, has acquired MicroSun Technologies, a provider of customized power solutions for medical devices. Both the companies are involved in manufacturing lithium ...
Tags: Palladium Energy, MicroSun Technologies, medical devices
Tandem Diabetes Care, a provider of diabetes management devices, has announced the availability of its t:slim Insulin Pump to customers. The t:slim Insulin Pump features an FDA-approved touch screen which provides a new approach to ...
Tags: T:Slim Insulin Pump, medical application, medical technology
Insulet, a provider of tubeless insulin pump technology, has reported a net loss of $12.42m, or $0.26 per share, for the third quarter ended 30 September 2012 compared to a net loss of $13.56m, or $0.29 per diluted share, for the third ...
Tags: Insulet, tubeless insulin pump technology, Financial situation
Roche has announced the US launch of ACCU-CHEK Combo system, designed for people with diabetes condition. The system, which combines a blood glucose meter with an insulin pump, utilizes Bluetooth technology for two-way wireless ...
Tags: diabetes therapy, clinical application, clinical technology
Roche's Accu-Chek Combo system has been cleared by the US Food and Drug Administration (FDA) for insulin pump therapy. The Accu-Chek Combo system features an insulin cartridge that can hold up to 315 units of insulin, as well as a ...
Spring Health Solutions, a subsidiary of D Medical Industries, has signed a non-exclusive US distribution agreement with an undisclosed party for its Spring Universal Infusion Sets. D Medical chief executive officer Efri Argaman said ...
Tags: distribution agreement, Universal Infusion Set, clinical technology
Spring Health Solutions and Spring Set Health Solutions, subsidiaries of D Medical Industries, have received first payment pursuant to original equipment manufacturer (OEM) agreement signed with Twobiens. The three year agreement ...
Tags: Detach Detect Infusion Sets, company cooperation, clinical device
Janssen Research & Development has submitted a New Drug Application (NDA) to the US FDA seeking approval for a fixed-dose therapy combining canagliflozin and immediate release metformin to treat patients with type 2 diabetes. ...
GI Dynamics has obtained conditional approval from the US Food and Drug Administration (FDA) to initiate a pivotal clinical trial of its non-surgical EndoBarrier device. Flexible, tube-shaped EndoBarrier liner, which forms a physical ...
Tags: GI Dynamics, conditional approval, FDA, pivotal clinical trial
Medtronic has obtained the CE mark approval for its Sentrino continuous glucose monitor (CGM), designed for use in hospital critical care units (CCU). Designed to optimize glucose management, the minimally invasive system displays ...
Tags: CGM, continuous glucose monitor, Medtronic, CCU
Teva Pharmaceutical Industries has unveiled authorized generic of Actos (pioglitazone-hydrochloride tablets) 15mg, 30mg and 45mg in the US. Actos is marketed by Takeda Pharmaceuticals USA and used with diet and exercise to improve blood ...
The US FDA has approved Novo Nordisk Victoza (liraglutide [rDNA] injection) label to include data showing superior blood sugar control and weight reduction when compared to Januvia (sitagliptin). Label update also includes approval of ...
Tags: Label update, type 2 diabetes, Victoza